CN102149721A - 用于治疗疼痛的氨基膦衍生物 - Google Patents
用于治疗疼痛的氨基膦衍生物 Download PDFInfo
- Publication number
- CN102149721A CN102149721A CN2009801355925A CN200980135592A CN102149721A CN 102149721 A CN102149721 A CN 102149721A CN 2009801355925 A CN2009801355925 A CN 2009801355925A CN 200980135592 A CN200980135592 A CN 200980135592A CN 102149721 A CN102149721 A CN 102149721A
- Authority
- CN
- China
- Prior art keywords
- group
- amino
- compound
- benzyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/306—Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/303—Cycloaliphatic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/32—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/32—Esters thereof
- C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/32—Esters thereof
- C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/3241—Esters of arylalkanephosphinic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/48—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof
- C07F9/4808—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
- C07F9/4816—Acyclic saturated acids or derivatices which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
溶解之后的时间 | 0hrs | 3hrs | 6hrs | 96hrs |
初始化合物% | 90.5% | 82.0% | 75.7% | 25.1% |
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0855015 | 2008-07-23 | ||
FR0855015A FR2934267B1 (fr) | 2008-07-23 | 2008-07-23 | Derives aminophosphiniques utiles dans le traitement de la douleur |
PCT/EP2009/059394 WO2010010106A1 (fr) | 2008-07-23 | 2009-07-22 | Derives aminophosphiniques utiles dans le traitement de la douleur |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102149721A true CN102149721A (zh) | 2011-08-10 |
CN102149721B CN102149721B (zh) | 2015-01-28 |
Family
ID=40336403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200980135592.5A Active CN102149721B (zh) | 2008-07-23 | 2009-07-22 | 用于治疗疼痛的氨基膦衍生物 |
Country Status (17)
Country | Link |
---|---|
US (2) | US8703747B2 (zh) |
EP (2) | EP2326655B1 (zh) |
JP (1) | JP5607045B2 (zh) |
KR (1) | KR101631726B1 (zh) |
CN (1) | CN102149721B (zh) |
AU (1) | AU2009273238A1 (zh) |
BR (1) | BRPI0916811B1 (zh) |
CA (1) | CA2731544C (zh) |
DK (2) | DK2326655T3 (zh) |
ES (2) | ES2533851T3 (zh) |
FR (1) | FR2934267B1 (zh) |
HK (1) | HK1160471A1 (zh) |
IL (1) | IL210760A (zh) |
MX (1) | MX2011000867A (zh) |
RU (1) | RU2011106300A (zh) |
WO (1) | WO2010010106A1 (zh) |
ZA (1) | ZA201101424B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108289901A (zh) * | 2015-11-30 | 2018-07-17 | 领先药物公司 | 用于预防和治疗眼痛的氨基次膦酸衍生物 |
TWI771386B (zh) * | 2017-03-09 | 2022-07-21 | 法商領先藥物公司 | 用於預防及治療眼發炎的氨基膦衍生物 |
CN114787171A (zh) * | 2019-12-11 | 2022-07-22 | 领先药物公司 | ((2s)-3-([1,1’-联苯]-4-基)-2-((羟基((1r)-1-(((1-(异丁酰氧基)乙氧基)羰基)氨基)乙基)磷酰基)甲基)丙酰基)-l-丙氨酸的二钠盐的工业制备方法 |
CN114787171B (zh) * | 2019-12-11 | 2024-05-14 | 智腾大中华区有限公司 | 一种化合物的工业制备方法 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2934267B1 (fr) * | 2008-07-23 | 2010-08-13 | Pharmaleads | Derives aminophosphiniques utiles dans le traitement de la douleur |
FR2997081B1 (fr) | 2012-10-23 | 2015-11-27 | Pharmaleads | Inhibiteurs mixtes de l'aminopeptidase n et de la neprilysine |
CN105503947B (zh) * | 2015-12-31 | 2018-07-24 | 遵义医学院 | 一种含氨基酸片段的膦酸酯衍生物的制备方法及抗肿瘤应用 |
FR3063635B1 (fr) * | 2017-03-09 | 2019-06-07 | Pharmaleads | Derives aminophosphiniques pour la prevention et le traitement de l'inflammation oculaire |
FR3077201B1 (fr) | 2018-01-26 | 2020-01-17 | Pharmaleads | Derives aminoacides contenant un groupement disulfanyle sous forme d'un inhibiteur de nep et d'apn pour la prevention et le traitement des douleurs relatives au nerf trijumeau |
TW202029962A (zh) * | 2018-10-26 | 2020-08-16 | 法商量子基因科技有限公司 | 胺肽酶a抑制劑及包含其的醫藥組合物 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR853092A (fr) | 1938-06-20 | 1940-03-09 | Dispositif d'éclairage arrière pour véhicules, notamment pour véhicules automobiles | |
FR2518088B1 (fr) | 1981-12-16 | 1987-11-27 | Roques Bernard | Nouveaux derives d'aminoacides, et leur application therapeutique |
FR2605004B1 (fr) | 1986-09-25 | 1989-01-13 | Centre Nat Rech Scient | Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant |
FR2651229B1 (fr) | 1989-08-24 | 1991-12-13 | Inst Nat Sante Rech Med | Nouveaux derives d'amino-acides, leur procede de preparation et leur application therapeutique. |
IT1270260B (it) * | 1994-06-21 | 1997-04-29 | Zambon Spa | Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi |
US5476847A (en) * | 1994-06-29 | 1995-12-19 | Schering Corporation | Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors |
IT1276710B1 (it) * | 1995-06-14 | 1997-11-03 | Zambon Spa | Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi |
US5597936A (en) | 1995-06-16 | 1997-01-28 | The Procter & Gamble Company | Method for manufacturing cobalt catalysts |
JPH0987291A (ja) * | 1995-09-26 | 1997-03-31 | Wakamoto Pharmaceut Co Ltd | 新規なアラニン誘導体 |
FR2755135B1 (fr) * | 1996-10-25 | 2002-12-27 | Inst Nat Sante Rech Med | Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent |
KR100537707B1 (ko) * | 1997-09-08 | 2005-12-20 | 워너-램버트 캄파니 엘엘씨 | 항간질 화합물을 포함하는 진통제 조성물 및 이의 사용 방법 |
FR2777780B1 (fr) * | 1998-04-22 | 2001-05-04 | Inst Nat Sante Rech Med | Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent |
US6113915A (en) * | 1999-10-12 | 2000-09-05 | Allergan Sales, Inc. | Methods for treating pain |
ES2369256T3 (es) | 2000-06-26 | 2011-11-28 | Helen Of Troy Limited | Sistema de lámpara recargable. |
FR2834989B1 (fr) * | 2002-01-18 | 2005-05-20 | Commissariat Energie Atomique | Derives de pseudo-peptides phosphiniques inhibant selectivement le site actif c-terminal de l'enzyme de conversion de l'angiotensine i(ace) |
EP1716160B1 (en) * | 2004-01-23 | 2010-12-29 | Janssen Pharmaceutica NV | Novel inhibitors of chymase |
US7494985B2 (en) * | 2004-11-03 | 2009-02-24 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
FR2882752B1 (fr) * | 2005-03-01 | 2007-05-04 | Servier Lab | Nouveaux derives d'aminoacides phosphiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2931151A1 (fr) * | 2008-05-13 | 2009-11-20 | Pharmaleads Soc Par Actions Si | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique |
FR2934267B1 (fr) * | 2008-07-23 | 2010-08-13 | Pharmaleads | Derives aminophosphiniques utiles dans le traitement de la douleur |
-
2008
- 2008-07-23 FR FR0855015A patent/FR2934267B1/fr active Active
-
2009
- 2009-07-22 BR BRPI0916811-7A patent/BRPI0916811B1/pt active IP Right Grant
- 2009-07-22 EP EP09780902.4A patent/EP2326655B1/fr active Active
- 2009-07-22 AU AU2009273238A patent/AU2009273238A1/en not_active Abandoned
- 2009-07-22 JP JP2011519156A patent/JP5607045B2/ja active Active
- 2009-07-22 DK DK09780902.4T patent/DK2326655T3/en active
- 2009-07-22 EP EP14157306.3A patent/EP2740736B1/fr active Active
- 2009-07-22 CA CA2731544A patent/CA2731544C/fr active Active
- 2009-07-22 ES ES09780902.4T patent/ES2533851T3/es active Active
- 2009-07-22 MX MX2011000867A patent/MX2011000867A/es active IP Right Grant
- 2009-07-22 KR KR1020117004013A patent/KR101631726B1/ko active IP Right Grant
- 2009-07-22 ES ES14157306.3T patent/ES2561579T3/es active Active
- 2009-07-22 WO PCT/EP2009/059394 patent/WO2010010106A1/fr active Application Filing
- 2009-07-22 CN CN200980135592.5A patent/CN102149721B/zh active Active
- 2009-07-22 DK DK14157306.3T patent/DK2740736T3/en active
- 2009-07-22 US US13/055,096 patent/US8703747B2/en active Active
- 2009-07-22 RU RU2011106300/04A patent/RU2011106300A/ru unknown
-
2011
- 2011-01-20 IL IL210760A patent/IL210760A/en active IP Right Grant
- 2011-02-23 ZA ZA2011/01424A patent/ZA201101424B/en unknown
-
2012
- 2012-01-30 HK HK12100836.4A patent/HK1160471A1/zh unknown
-
2014
- 2014-02-18 US US14/182,611 patent/US10131681B2/en active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108289901A (zh) * | 2015-11-30 | 2018-07-17 | 领先药物公司 | 用于预防和治疗眼痛的氨基次膦酸衍生物 |
TWI771386B (zh) * | 2017-03-09 | 2022-07-21 | 法商領先藥物公司 | 用於預防及治療眼發炎的氨基膦衍生物 |
CN114787171A (zh) * | 2019-12-11 | 2022-07-22 | 领先药物公司 | ((2s)-3-([1,1’-联苯]-4-基)-2-((羟基((1r)-1-(((1-(异丁酰氧基)乙氧基)羰基)氨基)乙基)磷酰基)甲基)丙酰基)-l-丙氨酸的二钠盐的工业制备方法 |
CN114787171B (zh) * | 2019-12-11 | 2024-05-14 | 智腾大中华区有限公司 | 一种化合物的工业制备方法 |
Also Published As
Publication number | Publication date |
---|---|
US10131681B2 (en) | 2018-11-20 |
EP2326655A1 (fr) | 2011-06-01 |
ES2533851T3 (es) | 2015-04-15 |
DK2740736T3 (en) | 2016-03-07 |
AU2009273238A1 (en) | 2010-01-28 |
BRPI0916811B1 (pt) | 2022-02-01 |
CN102149721B (zh) | 2015-01-28 |
JP2011528692A (ja) | 2011-11-24 |
FR2934267A1 (fr) | 2010-01-29 |
EP2326655B1 (fr) | 2014-12-31 |
MX2011000867A (es) | 2011-04-05 |
WO2010010106A1 (fr) | 2010-01-28 |
FR2934267B1 (fr) | 2010-08-13 |
IL210760A0 (en) | 2011-03-31 |
RU2011106300A (ru) | 2012-08-27 |
US8703747B2 (en) | 2014-04-22 |
CA2731544A1 (fr) | 2010-01-28 |
JP5607045B2 (ja) | 2014-10-15 |
EP2740736A1 (fr) | 2014-06-11 |
CA2731544C (fr) | 2017-08-22 |
ZA201101424B (en) | 2011-10-26 |
KR20110053336A (ko) | 2011-05-20 |
EP2740736B1 (fr) | 2015-12-09 |
ES2561579T3 (es) | 2016-02-29 |
HK1160471A1 (zh) | 2012-08-17 |
KR101631726B1 (ko) | 2016-06-17 |
US20110124601A1 (en) | 2011-05-26 |
DK2326655T3 (en) | 2015-04-13 |
US20140161839A1 (en) | 2014-06-12 |
IL210760A (en) | 2014-06-30 |
BRPI0916811A2 (pt) | 2020-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102149721B (zh) | 用于治疗疼痛的氨基膦衍生物 | |
AU749425B2 (en) | Prodrugs of NAALADase inhibitors | |
AU733880B2 (en) | Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals | |
LV12232B (en) | KNOWLEDGE PHOSPHINILATED DERIVATIVES AS NECESSARY INHIBITORS | |
JPH04243829A (ja) | N−置換アミノアルカンホスフィン酸 | |
AU2004249178B2 (en) | Substituted piperidine compounds and methods of their use | |
EP0371921B1 (de) | Phenylaliphatylaminoalkandi-phosphonsäuren | |
WO1998053812A1 (en) | Inhibitors of naaladase enzyme activity | |
CN102026966B (zh) | 新型氨基酸衍生物、其制备方法和治疗用途 | |
BRPI0610022A2 (pt) | compostos fluoroquinolonas fosfonadas, seus análogos antibacterianos, composição farmacêutica que os contém, bem como o uso dos mesmos | |
EP1487459A1 (en) | Peptide analogues and uses thereof | |
AU3982197A (en) | Inhibitors of naaladase enzyme activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1160471 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1160471 Country of ref document: HK |
|
TR01 | Transfer of patent right |
Effective date of registration: 20230505 Address after: Room D, 4F, Willie Building, 97 Wellington Street, Central, Hong Kong, China Patentee after: Zhiteng Greater China Co.,Ltd. Address before: Paris France Patentee before: PHARMALEADS |
|
TR01 | Transfer of patent right |